Is LQDA Worth Buying in 2026?

Liquidia Corporation Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Liquidia Corporation Common Stock (LQDA) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+6.69% over 10 days); RSI 35 — healthy momentum range; strong 1-year return of +185.3%; 3-month momentum positive (+30.8%); rising volume confirms the move (1.19x 30d avg). Concerns: below the 50-day MA (medium-term momentum negative). Currently 20.5% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

LQDA is holding above its long-term 200-day MA ($48.02) but has slipped below the 50-day MA ($78.16), pointing to short-term weakness in an otherwise intact trend. An RSI of 35.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +185.3% compares to +20.4% for SPY (beat the market by 164.9%). The current 20.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $28,532 today
vs. S&P 500 (SPY) — same period beat market by 164.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($48.02)
Above 50-day MA ($78.16)
RSI(14) neutral zone (30–70) — currently 35.3
Positive return (+185.3%)
!Within 10% of period high (−20.5%)
Period Range $74.44
$21.15 $93.61
RSI (14) 35.3
0 · OversoldOverbought · 100

Key Metrics

Price$74.44
Period Return+185.3%
Period High$93.61
Period Low$21.15
Drawdown−20.5%
MA-50$78.16
MA-200$48.02
RSI (14)35.3
Avg Volume (30d)1.6M
vs. SPYbeat by 164.9%
Return Rank#64 of 1252

Trade LQDA

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers